Conditions
One sample, many conditions.
A single Q-Pad collection event opens diagnostic access across cervical cancer and STIs, endometriosis, heavy menstrual bleeding, the menopause transition, fertility and hormones, and gynecologic cancers. Each condition has its own page covering care path, existing science, and Qvin's working role.
Browse conditions
Six conditions, one infrastructure.
-
Cervical cancer · STIs · BV
Gynecologic infection screening on a single sample.
-
Endometriosis
A disease defined by diagnostic delay — and by misplaced endometrial tissue.
-
Heavy menstrual bleeding
The most common reason women see a gynecologist — still managed without molecular tools.
-
Menopause transition
A decade of physiology with virtually no longitudinal monitoring.
-
Fertility & hormones
Repeated, at-home, multi-marker hormonal monitoring without phlebotomy.
-
Endometrial cancer
A gynecologic cancer with no screening test — and the tissue of origin in the menstrual sample.
Cross-cutting research
Programs that cut across condition silos.
Beyond the per-condition work, Qvin runs platform-layer programs that operate at the level of menstrual biology rather than a single condition:
- Comparative biospecimens — cycle mapping — characterizing the cyclical proteome and methylome of menstrual blood and comparing it with venous blood, vaginal swabs, rectal swabs, and saliva across the menstrual cycle.
- Multi-omics & precision medicine — deep phenotyping using menstrual blood as a recurring at-home sample within a longitudinal multi-omics framework.
Additional research collaborators contribute condition-specific work referenced on the per-condition pages. Specific institutional collaborators are reserved until each program is individually cleared for public disclosure. See Commercial for how partnerships are structured.